Reardon Andrew sold LGND
February 14, 2026 · Form 4 insider transaction
Reardon Andrew sold 4,083 shares of Ligand Pharmaceuticals Incorporated at $183.83 per share, a transaction worth $750.6K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,083
Price
$183.83
Total value
$750.6K
InsiderReardon Andrew
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 14, 2026
Filing dateFebruary 18, 2026
Shares owned after39,255
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of PSUs.